Sss Biocare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 2.60 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
About Sss Biocare Pharmaceuticals
Sss Biocare Pharmaceuticals Private Limited (SBPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 November 2019 (Five years and two months 22 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹1.00 Cr.
Srinivas Sandhi, Venkat Tirumala, and Bhavani Saluweru serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2019PTC137000
-
Company No.
137000
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sss Biocare Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Sandhi
|
Director | 20-Nov-2019 | Current |
|
Venkat Tirumala
|
Director | 20-Nov-2019 | Current |
|
Bhavani Saluweru
|
Director | 20-Nov-2019 | Current |
Financial Performance of Sss Biocare Pharmaceuticals.
Sss Biocare Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sss Biocare Pharmaceuticals?
Unlock access to Sss Biocare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2023 | Axis Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Sss Biocare Pharmaceuticals?
Sss Biocare Pharmaceuticals has a workforce of 47 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sss Biocare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sss Biocare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
